Cargando…
Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome
There is no specific treatment for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome (PA-HSOS). It is not clear when transjugular intrahepatic portosystemic shunt (TIPS) should be implemented in PA-HSOS patients. This study aimed to evaluate the timing of TIPS using total biliru...
Autores principales: | Wu, Fan, Yu, Jiao, Gan, Hongying, Zhang, Heng, Tian, Deying, Zheng, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571302/ https://www.ncbi.nlm.nih.gov/pubmed/34741082 http://dx.doi.org/10.1038/s41598-021-01201-w |
Ejemplares similares
-
Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome
por: Zhou, Chun-Ze, et al.
Publicado: (2020) -
Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum
por: Zhang, Lijie, et al.
Publicado: (2021) -
Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids
por: Luo, Shihua, et al.
Publicado: (2018) -
Biliary Obstruction After Transjugular Intrahepatic Portosystemic Shunt Placement
por: Patel, Feenalie, et al.
Publicado: (2021) -
The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014)